Halozyme Therapeutics, Inc.

FULLER & THALER ASSET MANAGEMENT, INC. HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

1,379,575

Value ($000)

92,845

Weight

0.3%

2020 Q1 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	92,845	0.3%	1,379,575	12/31/2025
2025 Q3	11/13/2025	100,563	0.3%	1,371,184	9/30/2025
2025 Q2	8/14/2025	64,661	0.2%	1,243,008	6/30/2025
2025 Q1	5/13/2025	72,107	0.3%	1,130,019	3/31/2025
2024 Q4	2/14/2025	42,448	0.2%	887,852	12/31/2024
2024 Q3	11/13/2024	47,140	0.2%	823,544	9/30/2024
2024 Q2	8/9/2024	37,520	0.2%	716,573	6/30/2024
2024 Q1	5/13/2024	23,121	0.1%	568,361	3/31/2024
2023 Q4	2/13/2024	15,142	0.1%	409,682	12/31/2023
2023 Q3	11/13/2023	14,073	0.1%	368,394	9/30/2023
2023 Q2	8/14/2023	12,192	0.1%	338,002	6/30/2023
2021 Q4	2/9/2022	11,229	0.1%	279,263	12/31/2021
2021 Q3	11/10/2021	11,520	0.1%	283,184	9/30/2021
2021 Q2	8/13/2021	13,979	0.1%	307,833	6/30/2021
2021 Q1	5/13/2021	15,818	0.1%	379,411	3/31/2021
2020 Q4	2/11/2021	15,927	0.1%	372,917	12/31/2020
2020 Q3	11/9/2020	9,599	0.1%	365,271	9/30/2020
2020 Q2	8/13/2020	10,708	0.1%	399,406	6/30/2020
2020 Q1	5/6/2020	6,642	0.1%	369,199	3/31/2020